Based in Italy, EryDel is a startup. Brouky records 1 investor associated with the company.
Develops a drug delivery platform that encapsulates therapeutic molecules into a patient’s own red blood cells (erythrocytes) to use them as vehicles for sustained or targeted delivery of drugs.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.